<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02301429</url>
  </required_header>
  <id_info>
    <org_study_id>LV DDD</org_study_id>
    <nct_id>NCT02301429</nct_id>
  </id_info>
  <brief_title>Model 20105 Lead Study</brief_title>
  <official_title>Model 20105 Lead Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic BRC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic BRC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the implant procedure and feasibility of a new lead
      developed to pace and sense the left chambers of the heart.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Low implant success rate(46%). For the successfull implants, 3month FU and available electrical
    data showed an increase in threshold values for the left atrium
  </why_stopped>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All Implant Procedure and Lead Related Adverse Events Will be Collected During the First Month Post Implant and Analyzed.</measure>
    <time_frame>1 month</time_frame>
    <description>All Implant procedure and lead related adverse events will be collected during the first month post implant and analyzed.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Sick Sinus Node Syndrome</condition>
  <arm_group>
    <arm_group_label>Model 20105</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receiving the model 20105 Lead</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Model 20105</intervention_name>
    <description>implant and follow-up of study device</description>
    <arm_group_label>Model 20105</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has Cardiac pacing indication for sinus node dysfunction (dual chamber
             pacemaker)

          -  Subject has signed and dated the study-specific informed consent form

          -  Subject is 18 years of age or older

          -  Subject is willing, able and committed to participate in Baseline and Follow-up and
             study procedures for the full length of the study

        Exclusion Criteria:

          -  Subject is indicated for BiV pacemaker or ICD

          -  Subject is pacing dependent

          -  Subject has a previous Pacemaker System

          -  Subject has known coronary venous vasculature that is inadequate for lead placement

          -  Subject has unstable angina pectoris or has had an acute myocardial infarction (MI)
             within the last month

          -  Subject has had a coronary artery bypass graft (CABG) or percutaneous transluminal
             coronary angioplasty (PTCA) within the past three months

          -  Subject is not in sinus rhythm at implant

          -  Subject has had a heart transplant (patients waiting for heart transplants are allowed
             in the study)

          -  Subject has known renal insufficiency that would prevent them from receiving an
             occlusive venogram during the implant procedure

          -  Subject is contraindicated for &lt;1mg dexamethasone acetate

          -  Subject is enrolled in any concurrent drug and/or device study that may confound the
             results of this study

          -  Subject has a terminal illness and is not expected to survive more than 6 months

          -  Subject is a pregnant woman or woman of childbearing potential not on adequate birth
             control.

          -  Subject is employed by Medtronic or by the department of any of the investigators or
             is a close relative of any of the investigators.

          -  Legal incapacity or evidence that a subject cannot understand the purpose and risks of
             the study

          -  Subject meets exclusion criteria required by local law.

          -  Subject is unable to tolerate an urgent thoracotomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>London Teaching Hospital</name>
      <address>
        <city>London</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Reinier de Graaf Hospital</name>
      <address>
        <city>Delft</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NUHCS, National University Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Milpark hospital</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Netherlands</country>
    <country>Singapore</country>
    <country>South Africa</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2014</study_first_submitted>
  <study_first_submitted_qc>November 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2014</study_first_posted>
  <results_first_submitted>September 2, 2016</results_first_submitted>
  <results_first_submitted_qc>September 2, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 26, 2016</results_first_posted>
  <last_update_submitted>September 2, 2016</last_update_submitted>
  <last_update_submitted_qc>September 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sick Sinus Syndrome</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Model 20105</title>
          <description>Receiving the model 20105 Lead
Model 20105: implant and follow-up of study device</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>not acceptable vascular anatomy</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Model 20105</title>
          <description>Receiving the model 20105 Lead
Model 20105: implant and follow-up of study device</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73.2" spread="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>QRS duration</title>
          <units>msec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="108.7" spread="17.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>All Implant Procedure and Lead Related Adverse Events Will be Collected During the First Month Post Implant and Analyzed.</title>
        <description>All Implant procedure and lead related adverse events will be collected during the first month post implant and analyzed.</description>
        <time_frame>1 month</time_frame>
        <population>all subject who underwent a Model 20105 Lead implant attempt are considered in this analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Model 20105</title>
            <description>Receiving the model 20105 Lead
Model 20105: implant and follow-up of study device</description>
          </group>
        </group_list>
        <measure>
          <title>All Implant Procedure and Lead Related Adverse Events Will be Collected During the First Month Post Implant and Analyzed.</title>
          <description>All Implant procedure and lead related adverse events will be collected during the first month post implant and analyzed.</description>
          <population>all subject who underwent a Model 20105 Lead implant attempt are considered in this analysis</population>
          <units>Adverse Events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Model 20105</title>
          <description>Receiving the model 20105 Lead
Model 20105: implant and follow-up of study device</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Coronary Sinus Dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Iatrogenic pneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Coronary Artery Stent Insertion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrioventricular nodal reentrant tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Angina Pectoris</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Coronary Sinus Dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Study manager</name_or_title>
      <organization>Medtronic Regional Clinical Center</organization>
      <phone>0039(0)22 241371</phone>
      <email>laura.manotta@medtronic.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

